Poliovirus vaccine inactivated - Intravacc/Sinovac/WHO

Drug Profile

Poliovirus vaccine inactivated - Intravacc/Sinovac/WHO

Alternative Names: Inactivated poliovirus vaccine - Intravacc/Sinovac/WHO; Poliovirus inactivated vaccine - Intravacc/Sinovac/WHO; Sabin inactivated polio vaccine - Intravacc/Sinovac/WHO; Sabin IPV - Intravacc/Sinovac/WHO; sIPV - Intravacc/Sinovac/WHO

Latest Information Update: 24 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Intravacc; National Institute of Public Health and the Environment; World Health Organization
  • Developer Intravacc; National Institute for Public Health and the Environment; Sinovac Biotech
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Poliomyelitis

Most Recent Events

  • 23 Apr 2018 Initial efficacy data from a phase III trial in poliomyelitis (Prevention) released by Sinovac Biotech
  • 01 Dec 2017 Sinovac Biotech completes a phase II trial for Poliomyelitis (In infants, Prevention) in China before December 2017
  • 15 Sep 2017 Intravacc plans to obtain market approval for polio vaccine inactivated (Sabin-IPV) in January 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top